These initial clinical results support the concept of DPP1 inhibition as a potential therapeutic strategy across multiple inflammatory diseases that involve excessive NSP secretion or neutrophil dysregulation and hyperresponsiveness
Neuropsychiatric disease and treatment 4(1):6979 Mignot E et al (2022) Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
In a PI-IBS model, berberine treatment resulted in the downregulation of Proteobacteria and pathogenic Escherichia/Shigella strains, while promoting beneficial genera such as Lactobacillus , Clostridium IV , and Ruminococcus
Furthermore, it should be administered with caution in patients with renal impairment, as it may heighten the risk of adverse reactions
WHO-GMP, ISO 9001:2015 & DCGI approved manufacturing since 1981